Hideaki Shimada-Hideaki

Omorinaka, 1438541, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patients.

Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patients.

Journal: Surgery today

Published: September 25, 2024

Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.

Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.

Journal: Journal of gastroenterology

Published: June 18, 2024

Can Immune Checkpoint Inhibitors Pave the New Way for "Conversion Surgery" in Unresectable Esophageal Cancer?

Can Immune Checkpoint Inhibitors Pave the New Way for "Conversion Surgery" in Unresectable Esophageal Cancer?

Journal: Annals of surgical oncology

Published: May 20, 2024

Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer.

Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer.

Journal: Journal of gastrointestinal cancer

Published: May 18, 2024

Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.

Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.

Journal: International journal of clinical oncology

Published: January 31, 2024

The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study.

The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study.

Journal: International journal of clinical oncology

Published: January 10, 2024

Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1.

Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1.

Journal: International journal of clinical oncology

Published: August 31, 2023

Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma.

Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: March 08, 2022

Prognostic significance of preoperative low serum creatine kinase levels in gastric cancer.

Prognostic significance of preoperative low serum creatine kinase levels in gastric cancer.

Journal: Surgery today

Published: December 17, 2021

Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers.

Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers.

Journal: International journal of clinical oncology

Published: August 05, 2021

Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma.

Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: March 18, 2021

ASO Author Reflections: New Assay System to Detect Serum Anti-p53 Antibodies.

ASO Author Reflections: New Assay System to Detect Serum Anti-p53 Antibodies.

Journal: Annals of surgical oncology

Published: October 28, 2020

Showing 1-12 of 42

Last Updated: 09/26/2026